FDA Inspection 964643 — Haupt Pharma Wolfratshausen GmbH

Haupt Pharma Wolfratshausen GmbH — FEI 3000310230

The FDA completed an inspection of Haupt Pharma Wolfratshausen GmbH on April 9, 2016 in Wolfratshausen. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 9, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Wolfratshausen (Germany)